Merck Capvaxive gets USFDA nod for prevention of Invasive Pneumococcal Disease, Pneumococcal Pneumonia in adults Ruchika Sharma18 Jun 2024 2:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Contact with kids most important factor in the onward transmission of pneumococcal pneumonia to elderly: Study Dr. Kamal Kant Kohli5 April 2024 8:15 PM ISTSpain: A recent study has suggested the main benefit of adult pneumococcal vaccination is to directly protect older adults exposed to children who may...
USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults Ruchika Sharma21 Dec 2023 3:47 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Pneumococcal vaccine gets USFDA Breakthrough Therapy Designation Ruchika Sharma16 April 2022 12:47 PM ISTThe Breakthrough Therapy Designation is an FDA program designed to expedite the development and review of products intended for serious or...
